Episode 1: The Convince Trial The recently published CONVINCE Trial revealed a 23% decrease in mortality rates for patients treated with high-volume hemodiafiltration compared to those treated with more commonly used high-flux hemodialysis. Learn more about one of the biggest randomized clinical trials in the dialysis field, with 1360 patients and median follow up of 30 months, addressing the question about the effect of high-volume HDF and high flux HD on mortality in kidney failure.
Link publication: Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure | NEJM CONVINCE STUDY (https://www.nejm.org/doi/full/10.1056/NEJMoa2304820) This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 754803.
Event Date: 12/5/2024